scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPGI.00073.2001 |
P698 | PubMed publication ID | 12016132 |
P50 | author | Rosemary A. Kozar | Q112372091 |
P2093 | author name string | Frederick A Moore | |
Lei Zou | |||
Bruce C Kone | |||
Heitham T Hassoun | |||
Norman W Weisbrodt | |||
P433 | issue | 6 | |
P921 | main subject | reperfusion injury | Q1413991 |
P304 | page(s) | G1059-68 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
P1476 | title | Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury | |
P478 | volume | 282 |
Q36681505 | AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality |
Q36728787 | Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms |
Q46938298 | Alpha-MSH rescues neurons from excitotoxic cell death |
Q36254148 | Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers |
Q79167572 | Delayed Administration of ??-Melanocyte-Stimulating Hormone or Combined Therapy with Bay 11-7085 Protects Against Gut Ischemia???Reperfusion Injury |
Q36466000 | Development of intestinal ischemia/reperfusion-induced acute kidney injury in rats with or without chronic kidney disease: Cytokine/chemokine response and effect of α-melanocyte-stimulating hormone |
Q42596989 | Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut. |
Q41873262 | Effects of α-MSH on ischemia/reperfusion injury in the rat sciatic nerve |
Q46375880 | Induction of cell death in rat small intestine by ischemia reperfusion: differential roles of Fas/Fas ligand and Bcl-2/Bax systems depending upon cell types |
Q37175638 | Intestinal edema: effect of enteral feeding on motility and gene expression |
Q54463873 | Intestinal ischemic preconditioning after ischemia/reperfusion injury in rat intestine: profiling global gene expression patterns. |
Q35916693 | Ischemia-reperfusion injury of the intestine and protective strategies against injury |
Q34988063 | MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer |
Q78339319 | Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy |
Q38005251 | Melanocortins as potential therapeutic agents in severe hypoxic conditions |
Q40663646 | Murine Model of Intestinal Ischemia-reperfusion Injury |
Q37238435 | Pretreatment with bone morphogenetic protein-7 (BMP-7) mimics ischemia preconditioning following intestinal ischemia/reperfusion injury in the intestine and liver |
Q61448838 | Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases |
Q34358639 | Protective role of p70S6K in intestinal ischemia/reperfusion injury in mice |
Q42451659 | Protein kinase C-ϵ modulates mitochondrial function and active Na+transport after oxidant injury in renal cells |
Q36081681 | Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut. |
Q42757138 | The effects of apelin on mesenteric ischemia and reperfusion damage in an experimental rat model |
Q35594078 | Transforming growth factor-beta 3 alters intestinal smooth muscle function: implications for gastroschisis-related intestinal dysfunction |
Search more.